Bio-Techne Corporation (TECH) Stock Overview
NASDAQ · Healthcare · Biotechnology
About Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial…
Source: Yahoo Finance
Sector & Industry
Bio-Techne Corporation operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Bio-Techne Corporation at a Glance
| Company | Bio-Techne Corporation |
| Ticker | TECH |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $72.12 |
| Market cap | $11.24B |
| P/E ratio (trailing) | 103.03 |
| EPS (trailing) | $0.70 |
| 52-week high | $72.16 |
| 52-week low | $43.20 |
| Dividend yield | 44.00% |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 3,100 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is Bio-Techne Corporation's P/E ratio?
Bio-Techne Corporation (TECH) has a trailing P/E ratio of 103.03 as of our latest data snapshot.
What is Bio-Techne Corporation's market cap?
Bio-Techne Corporation's market capitalisation is $11.24B based on the most recent snapshot.
What is TECH's 52-week range?
Over the past 52 weeks, TECH has traded between $43.20 and $72.16.
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: